Zentalis Pharmaceuticals (ZNTL)
(Real Time Quote from BATS)
$1.40 USD
+0.01 (0.72%)
Updated Aug 5, 2025 02:56 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Zentalis Pharmaceuticals, Inc. has a market cap of $100.01M, which represents its share price of $1.39 multiplied by its outstanding shares number of 71.95M. As a small-cap company, ZNTL's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ZNTL 1.40 +0.01(0.72%)
Will ZNTL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ZNTL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZNTL
Zentalis Pharmaceuticals (ZNTL) Loses -46.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zentalis Pharmaceuticals (ZNTL) Upgraded to Strong Buy: What Does It Mean for the Stock?
ZNTL: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for January 9th
Biotech Stock Roundup: GILD, NUVL Stocks Surge on Study Data, MRNA Down on Updates
Zentalis Stock Up as FDA Lifts Partial Hold on Cancer Drug Studies
Other News for ZNTL
Zentalis management to meet with Oppenheimer
ZNTL Hosts Investor Meetings in Mid-July | ZNTL Stock News
Zentalis management to meet with Oppenheimer
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | ZNTL ...
Zentalis Pharmaceuticals Holds 2025 Annual Stockholders Meeting